Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Garg R, Chen W, Pendergrass M
Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway
2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma by | Feb 5 | Market Access, Strategy INSIGHTS Home 9 Author archive for Kevin Cast Kevin Cast 2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma Four Pivotal Trends Revolutionizing Market Access Strategies 2025 Pharma Forecast Trends to Watch
The study, which tested the drug in 529 patients with obesity and heart failure with preserved ejection fraction (HFpEF), demonstrated a 16.6-point increase at 52 weeks, with regard to the Clinical Summary Score (CSS) on the Kansas City Cardiomyopathy Questionnaire (KCCQ) a measure of symptoms of heart failure in comparison to an 8.7-point increase in the placebo group
We are currently in an internal evaluation phase, reviewing the published research and running a structured internal protocol with our clinical team
